Jeffrey E. Poiley

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 496 citations

Medicine, Pharmacology, Pharmacotherapy +12

Peficitinib, a JAK Inhibitor, in the Treatment of Moderate‐to‐Severe Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate

Alan Kivitz, Sergio Gutiérrez‐Ureña, Jeffrey E. Poiley et al. · Arthritis & Rheumatology · 2016 · 109 citations

Medicine, Pharmacology, Pharmacotherapy +15

A Randomized, Double‐Blind, Active‐ and Placebo‐Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout

Jeffrey E. Poiley, Alexandra Steinberg, Yun‐Jung Choi et al. · Arthritis & Rheumatology · 2016 · 78 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Intra-articular orgotein in osteoarthritis of the knee: A placebo-controlled efficacy, safety, and dosage comparison

Harris McIlwain, Joel C. Silverfield, Don E. Cheatum et al. · The American Journal of Medicine · 1989 · 53 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +10

Tenidap in rheumatoid arthritis a 24‐week double‐blind comparison with hydroxychloroquine‐plus‐piroxicam, and piroxicam alone

Warren D. Blackburn, H. Malin Prupas, Joel C. Silverfield et al. · Arthritis & Rheumatism · 1995 · 44 citations

Medicine, Clinical Sciences, Pharmacotherapy +16